Increased in vivo phosphorylation state of neuromodulin and synapsin I in striatum from rats treated with repeated amphetamine

Journal of Pharmacology and Experimental Therapeutics

Volumn 278, Issue 3, 1996, Pages 1428-1434

  Iwata, Shin Ichi ^a,d   Hewlett, G H Keikilani ^a   Ferrell, Sandra T ^a   Czernik, Andrew J ^b   Meiri, Karina F ^c   Gnegy, Margaret E ^a,e  

^a UNIVERSITY OF MICHIGAN   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

^c SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^d KAGOSHIMA UNIVERSITY   (Japan)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; DOPAMINE; NEUROMODULIN; NEUROTRANSMITTER; PROTEIN KINASE (CALCIUM,CALMODULIN) II; PROTEIN KINASE C; SODIUM CHLORIDE; SYNAPSIN I;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN SYNAPTOSOME; CIRCLING BEHAVIOR; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DRUG INTERMITTENT THERAPY; DRUG REEXPOSURE; DRUG SENSITIZATION; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; STEREOTYPY;

ANIMALS; CALMODULIN; CORPUS STRIATUM; DEXTROAMPHETAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; GAP-43 PROTEIN; MEMBRANE GLYCOPROTEINS; NERVE TISSUE PROTEINS; PHOSPHORYLATION; PHOSPHOSERINE; RATS; SYNAPSINS; SYNAPTOSOMES;

EID: 0030434262     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. ALEXANDER, K. A., CIMLER, B. M., MEIER, K. E. AND STORM, D. R.: Regulation of calmodulin-binding to P-57. J. Biol. Chem. 262: 6108-6113, 1987.
2. CASTAÑEDA, E., BECKER, J. B. AND ROBINSON, T. E.: The long-term effects of repeated amphetamine treatment in vivo on amphetamine, KCl and electrical stimulation evoked striatal dopamine release in vitro. Life Sci. 42: 2447-2456, 1988.
3. COGGINS, P. J. AND ZWIERS, H.: B-50 (GAP-43): Biochemistry and functional neurochemistry of a neuron-specific phosphoprotein. J. Neurochem. 56: 1095-1106, 1991.
4. CREESE, I. AND IVERSEN, S. D.: The role of forebrain dopamine systems in amphetamine induced stereotyped behavior in the rat. Psychopharmacologia 39: 345-357, 1974.
5. CZERNIK, A. J., GIRAULT, J. A., NAIRN, A. C., CHEN, J., SNYDER, G., KEBABIAN, J. AND GREENGARD, P.: Production of phosphorylation state-specific antibodies. Methods Enzymol. 201: 264-283, 1991.
6. CZERNIK, A. J., MATHERS, J., TSOU, K., GREENGARD, P. AND MISCHE, S. M.: Phosphorylation state-specific antibodies: Preparation and applications. Neuroprotocols 6: 56-61, 1995.
7. D. E. CAMILLI, P., BENFENATI, F., VALTORTA, F. AND GREENGARD, P.: The synapsins. Annu. Rev. Cell Biol. 6: 433-460, 1990.
8. DEKKER, L. V., D. E. GRAAN, P. N. E., VERSTEEG, D. H. G., OBSTREICHER, A. B. AND GISPEN, W. H.: Phosphorylation of B-50 (GAP43) is correlated with neurotransmitter release in rat hippocampal slices. J. Neurochem. 52: 24-30, 1989.
9. 3H]noradrenaline release in rat brain synaptosomes. Eur. J. Pharmacol. 188: 113-122, 1990.
10. DUNKLEY, P. R., HEATH, J. W., HARRISON, S. M., JARVIE, P. E., GLENFIELD, P. J. AND ROSTAS, J. A. P.: A rapid Percoll gradient procedure for isolation of synaptosomes directly from an S1 fraction: homogeneity and morphology of subcellular fractions. Brain Res. 441: 59-71, 1988.
11. FISCHER, J. F. AND CHO, A. K.: Chemical release of dopamine from striatal homogenates: Evidence for an exchange diffusion model. J. Pharmacol. Exp. Ther. 192: 642-653, 1979.
12. GIAMBALVO, C. T.: Protein kinase C and dopamine transport-1. Effects of amphetamine in vivo. Neuropharmacology 31: 1201-1210, 1992.
13. GNEGY, M. E., HEWLETT, G. H. K., YEE, S. L. AND WELSH, M. J.: Alterations in calmodulin content and localization in areas of rat brain after repeated intermittent amphetamine. Brain Res. 562: 6-12, 1991.
14. GNEGY, M. E., HONG, P. AND FERRELL, S. T.: Phosphorylation of neuromodulin in rat striatum after acute and repeated, intermittent amphetamine. Brain Res.-Mol. Brain Res. 20: 289-298, 1993.
15. 2+/calmodulin and phosphorylation: Inhibition of actin binding and bundling. Biochemistry 34: 1912-1920, 1995.
16. GREENGARD, P., VALTORTA, F., CZERNIK, A. J. AND BENFENATI, F.: Synaptic vesicle phosphoproteins and regulation of synaptic function. Science 259: 780-785, 1993.
17. 2+-dependent interaction of calmodulin with the head domain of synapsin 1. Biochem. J. 275: 93-97, 1991.
18. HEFFNER, T. G., HARTMAN, J. A. AND SEIDEN, L. S.: A rapid method for the regional dissection of the rat brain. Pharmacol. Biochem. Behav. 13: 453-456, 1980.
19. 2+ trigger. J. Neurochem. 60: 1264-1273, 1993.
20. 2+-induced noradrenaline release, B-50 phosphorylation and dephosphorylation and calmodulin binding. J. Neurochem. 64: 1127-1136, 1995.
21. HERNANDEZ, L., LEE, F. AND HOEBEL, B. G.: Simultaneous microdialysis and amphetamine infusion in the nucleus accumbens and striatum of freely moving rats: Increase in extracellular dopamine and serotonin. Brain Res. Bull. 19: 623-628, 1987.
22. HIRABAYASHI, M. AND ALAM, M. R.: Enhancing effect of methamphetamine on ambulatory activity produced by repeated administration in mice. Pharmacol. Biochem. Behav. 15: 925-932, 1981.
23. KALIVAS, P. W. AND WEBER, B.: Amphetamine injection into the ventral mesencephalon sensitizes rats to peripheral amphetamine and cocaine. J. Pharmacol. Exp. Ther. 245: 1095-1102, 1988.
24. KARLER, R., CALDER, L. D. AND TURKANIS, S. A.: DNQX blockade of amphetamine behavioral sensitization. Brain Res. 552: 295-300, 1991.
25. KELLY, P. H., SEVIOUR, P. W. AND IVERSEN, S. D.: Amphetamine and apomorphine responses in the rat following 6-OHDA.: lesions of the nucleus accumbens septi and corpus striatum. Brain Res. 94: 507-522, 1975.
26. KOLTA, M. G., SHREVE, P., DE SOUZA, V. AND URETSKY, N. J.: Time course of the development of the enhanced behavioral and biochemical responses to amphetamine after pretreatment with amphetamine. Neuropharmacology. 24: 823-829, 1985.
27. KOLTA, M. G., SHREVE, P. AND URETSKY, N. J.: Effect of pretreatment with amphetamine on the interaction between amphetamine and dopamine neurons in the nucleus accumbens. Neuropharmacology 28: 9-14, 1989.
28. KUCZENSKI, R.: Dose response for amphetamine-induced changes in dopamine levels in push-pull perfusates of rat striatum. J. Neurochem. 46: 1605-1611, 1986.
29. KUCZENSKI, R. AND LEITH, N. J.: Chronic amphetamine: Is dopamine a link in or mediator of the development of tolerance and reverse tolerance? Pharm. Biochem. Behav. 15: 405-413, 1981.
30. KUCZENSKI, R. AND SEGAL, D.: Concomitant characterization of behavioral and striatal neurotransmitter response to amphetamine using in vivo microdialysis. J. Neurosci. 9: 2051-2065, 1989.
31. LIU, J.-P., SIM, A. T. R. AND ROBINSON, P. J.: Calcineurin inhibition of dynamin I GTPase activity coupled to nerve terminal depolarization. Science 265: 970-973, 1994.
32. LIU, Y. AND STORM, D. R.: Dephosphorylation of neuromodulin by calcineurin. J. Biol. Chem. 264: 12800-12804, 1989.
33. MANDEL, R. J., LEANZA, G., NILSSON, O. G. AND ROSENGREN, E.: Amphetamine induces excess release of striatal acetylcholine in vivo that is independent of nigrostriatal dopamine. Brain Res. 653: 57-65, 1994.
34. MATTHIES, H. J. G., MILLER, R. J. AND PALFREY, H. C.: Calmodulin binding to and cAMP-dependent phosphorylation of kinesin light chains modulate kinesin ATPase activity. J. Biol. Chem. 268: 11176-11187, 1993.
35. MEIRI, K. F., BICKERSTAFF, L. E. AND SCHWOB, J. E.: Monoclonal antibodies show that kinase C phosphorylation of GAP-43 during axonogenesis is both spatially and temporally restricted in vivo. J. Cell Biol. 112: 991-1005, 1991.
36. OKABE, T. AND SOBUE, K.: Identification of a new 84/82 kDa calmodulin-binding protein, which also interacts with actin filaments, tubulin and spectrin, as synapsin I. FEBS Lett. 213: 184-188, 1987.
37. PAULSON, P. E. AND ROBINSON, T. E.: Amphetamine-induced time-dependent sensitization of dopamine neurotransmission in the dorsal and ventral striatum: A microdialysis study in behaving rats. Synapse 19: 56-65, 1995.
38. PIERCE, R. C. AND KALIVAS, P. W.: The enhanced releasability of nucleus accumbens shell dopamine in rats behaviorally sensitized to cocaine is calcium-dependent. Soc. Neurosci. Abstr. 21: 714, 1995.
39. PIERIBONE, V. A., SHUPLIAKOV, O., BRODIN, L., HILFIKER-ROTHENFLUH, S., CZERNIK, A. J. AND GREENGARD, P.: Distinct pools of synaptic vesicles in neurotransmitter release. Nature 375: 493-497, 1995.
40. POPOV, N., SCHULZECK, S., NUSS, D., VOPEL, A.-U., JENDRNY, C., STRUY, H. AND MATTHIES, H.: Alterations in calmodulin content of rat brain areas after chronic application of haloperidol and amphetamine. Biomed. Biochim. Acta 47: 435-441, 1988.
41. ROBERTS-LEWIS, J. M., WELSH, M. J. AND GNEGY, M. E.: Chronic amphetamine treatment increases striatal calmodulin in rats. Brain Res. 384: 383-386, 1986.
42. ROBINSON, T. E.: Behavioral sensitization: Characterization of enduring changes in rotational behavior produced by intermittent injections of amphetamine in male and female rats. Psychopharmacology 84: 466-475, 1984.
43. ROBINSON, T. E.: The neurobiology of amphetamine psychosis: Evidence from studies with an animal model. In Taniguchi Symposia on Brain Sciences, ed. by T. Nakazawa, vol. 14, Biological Basis of Schizophrenic Disorders, pp. 185-201, Japan Scientific Societies Press, Tokyo, 1991.
44. ROBINSON, T. E. AND BECKER, J. B.: Behavioral sensitization is accompanied by an enhancement in amphetamine-stimulated dopamine release from striatal tissue in vitro. Eur. J. Pharmacol. 85: 253-254, 1982.
45. ROBINSON, T. E., BECKER, J. B. AND PRESTY, S. K.: Long-term facilitation of amphetamine-induced rotational behavior and striatal dopamine release produced by a single exposure to amphetamine: Sex differences. Brain Res. 253: 231-241, 1982.
46. ROBINSON, T. E. AND BECKER, J. B.: Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis. Brain Res. Rev. 11: 157-198, 1986.
47. ROBINSON, T. E., JURSON, P. A., BENNETT, J. A. AND BENTGEN, K. M.: Persistent sensitization of dopamine neurotransmission in ventral striatum (nucleus accumbens) produced by prior experience with (+)-amphetamine: A microdialysis study in freely moving rats. Brain Res. 462: 211-222, 1988.
48. ROSAHL, T. W., SPILLANE, D., MISSLER, M., HERZ, J., SELIG, D. K., WOLFF, J. R., HAMMER, R. E., MALENKA, R. C. AND SUDHOF, T. C.: Essential functions of synapsins I and II in synaptic vesicle regulation. Nature 375: 488-493, 1995.
49. ROSEBOOM, P. H., HEWLETT, G. H. K. AND GNEGY, M. E.: Repeated amphetamine administration alters the interaction between D1-stimulated adenylyl cyclase activity and calmodulin in rat striatum. J. Pharmacol. Exp. Ther. 255: 197-203, 1990.
50. SATO, M., CHEN, C.-C., AKIYAMA, K. AND OTSUKI, S.: Acute exacerbation of paranoid psychotic state after long-term abstinence in patients with previous methamphetamine psychosis. Biol. Psychiatry 18: 429-440, 1983.
51. SATO, M.: A lasting vulnerability to psychosis in patients with previous methamphetamine psychosis. Ann. NY Acad. Sci. 654: 160-170, 1992.
52. SEGAL, D. S. AND MANDELL, A. J.: Long-term administration of d-amphetamine: Progressive augmentation of motor activity and stereotypy. Pharmacol. Biochem. Behav. 2: 249-255, 1974.
53. SEIDEN, L. S., SABOL, K. E. AND RICAURTE, G. A.: Amphetamine: Effects on catecholamine systems and behavior. Annu. Rev. Pharmacol. Toxicol. 33: 639-677, 1993.
54. SKENE, J. H. P.: Axonal growth-associated proteins. Annu. Rev. Neurosci. 12: 127-156, 1989.
55. STEWART, J. AND VEZINA, P.: Microinjections of SCH-23390 into the ventral tegmental area and substantia nigra pars reticulata attenuate the development of sensitization to the locomotor activating effects of systemic amphetamine. Brain Res. 495: 401-406, 1989.
56. TERWILLIGER, R. Z., BEITNER-JOHNSON, D., SEVARINO, K. A., CRAIN, S. M. AND NESTLER, E. J.: A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function. Brain Res. 548: 100-110, 1991.
57. TRIPARO, J. M., VITALE, M. L. AND RODRIGUEZ DEL CASTILLO, A.: Cytoskeleton and molecular mechanisms in neurotransmitter release by neurosecretory cells. Eur. J. Pharmacol. 225: 83-104, 1992.
58. VALTORTA, F., BENFENATI, F. AND GREENGARD, P.: Structure and function of the synapsins. J. Biol. Chem. 267: 7195-7198, 1992.
59. VEZINA, P. AND STEWART, J.: The effect of dopamine receptor blockade on the development of sensitization to the locomotor activating effects of amphetamine and morphine. Brain Res. 499: 108-120, 1989.
60. WALAAS, S. I. AND GREENGARD, P.: DARPP-32, a dopamine- and adenosine 3′:5′-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. I. Regional and cellular distribution in the rat brain. J. Neurosci. 4: 84-98, 1984.
61. YAMAGATA, Y., OBATA, K., GEEENGARD, P. AND CZERNIK, A. J.: Increase in synapsin I phosphorylation implicates a presynaptic component in septal kindling. Neuroscience 64: 1-4, 1995.